Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

LiraglutideExplore study findings

What exercise and liraglutide changed in a weight-maintenance study

1 numbered sourceSource years 2026

Peptides are short chains of amino acids connected by peptide bonds. Some mimic signals that change appetite and glucose regulation. Liraglutide is a modified GLP-1 receptor agonist peptide. A 2026 analysis of the S-LiTE trial examined whether exercise, liraglutide or both changed measurements of blood vessel health after participants had already lost weight through a supervised program. [1]

The analysis included 130 adults with obesity. After an initial diet-based period, participants were randomized to groups that allowed researchers to compare exercise and liraglutide separately and together over 52 weeks. The investigators examined carotid intima-media thickness, a measurement of layers of the wall of an artery in the neck. They also examined circulating proteins associated with inflammation and the lining of blood vessels. This set of outcomes let them investigate several aspects of vascular biology. [1]

In the analysis, exercise alone and exercise with liraglutide were associated with reduced carotid wall thickness and lower levels of two inflammatory signaling proteins. The combination also improved some biomarkers associated with the vessel lining. The liraglutide-only group did not show the same improvements in the reported measures. The groups are important because the response with exercise and the drug together cannot be attributed solely to the peptide. [1]

The analysis was specified in advance as a secondary investigation of the trial. It tells readers how particular artery and blood measurements changed during maintenance after the initial weight-loss period. Those measurements can help scientists explore possible mechanisms. They do not count heart attacks or strokes, and a change in a marker cannot by itself establish a change in the risk of a particular clinical event. [1]

The maintenance setting matters as well. Participants were measured after a common initial weight-loss phase, so the study examined changes over the following year. A trial of starting liraglutide before any weight change would address a different question. The distinctive result here is the pattern across the separate exercise, medication and combination comparisons for defined vascular measures. [1]

Sources

Original works cited in this article. Links open the external record in a new tab.

Shop Liraglutide

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Also available as Markdown or JSON.